Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.27
Price to sales ratio
1.05
Dividends per share
Dividend yield %

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4217
BTMD
Biote Corp. - Class A common stock
1.57 USD-3.68%-2.48%-22.66%-53.27%56.41 M USD
4350
DCGO
DocGo Inc. - Common Stock
0.40 USD-2.44%-4.76%-38.46%-74.03%39.57 M USD
4406
SRXH
SRX Health Solutions, Inc. Common Stock
1.72 USD-3.37%-5.49%+17.01%+1222.06%34.86 M USD
4559
CCM
Concord Medical Services Holdings Limited American Depositary S
4.76 USD-2.86%-7.57%+9.43%+49.22%20.67 M USD

Frequently asked questions about Cryo-Cell International Inc.

What is the Cryo-Cell International Inc. stock price today?

The current price of Cryo-Cell International Inc. (CCEL) is 4.41. Over the past 24 hours, the stock has changed by +3.04%. Follow the CCEL chart for real-time price dynamics.

What is the stock ticker of Cryo-Cell International Inc.?

Cryo-Cell International Inc. trades under the ticker CCEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cryo-Cell International Inc. stock going up?

CCEL has changed by +1.61% over the last week, +24.58% over the last month, and +33.64% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Cryo-Cell International Inc.?

Cryo-Cell International Inc. currently has a market capitalization of 35.56 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Cryo-Cell International Inc. release financial reports?

Yes. You can track Cryo-Cell International Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Cryo-Cell International Inc. earnings last quarter?

Last quarter, Cryo-Cell International Inc. reported earnings of 0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Cryo-Cell International Inc. revenue for the last quarter?

Cryo-Cell International Inc. reported quarterly revenue of 7.62 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Cryo-Cell International Inc. net income for the last quarter?

Cryo-Cell International Inc. reported net income of 554.59 K for the last quarter. The previous quarter showed 47.11 K, which means net income changed by +1077.27%.

How many employees does Cryo-Cell International Inc. have?

As of the latest available data, Cryo-Cell International Inc. has 76 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cryo-Cell International Inc. EBITDA?

Cryo-Cell International Inc. EBITDA is 1.28 M, and its EBITDA margin is 16.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cryo-Cell International Inc. stock?

You can buy Cryo-Cell International Inc. (CCEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cryo-Cell International Inc. stock?

Investing in Cryo-Cell International Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CCEL chart and related analysis on metatrader.com as part of your research.

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

News